Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-29T09:21:45.927Z Has data issue: false hasContentIssue false

A new apathy scale for institutionalized dementia patients: validation of the APADEM-NH scale short-version

Published online by Cambridge University Press:  16 April 2020

M.I. Ramos-García
Affiliation:
Alzheimer's Disease Research Unit, Queen Sofia Foundation, Carlos III Institute of Health, Madrid, Spain
L. Agüera-Ortiz
Affiliation:
Alzheimer's Disease Research Unit, Queen Sofia Foundation, Carlos III Institute of Health, Madrid, Spain
N. Gil-Ruiz
Affiliation:
Alzheimer's Disease Research Unit, Queen Sofia Foundation, Carlos III Institute of Health, Madrid, Spain
I. Cruz-Orduña
Affiliation:
Alzheimer's Disease Research Unit, Queen Sofia Foundation, Carlos III Institute of Health, Madrid, Spain
M. Valentí-Soler
Affiliation:
Alzheimer's Disease Research Unit, Queen Sofia Foundation, Carlos III Institute of Health, Madrid, Spain
R. Osorio-Suárez
Affiliation:
Psychiatry, Center of Excellence on Brain Aging, University School of Medicine, New York, NY, USA
B. Reneses-Prieto
Affiliation:
Institute of Psychiatry and Mental Health, San Carlos Clinical Hospital, Madrid, Spain
P. Martinez-Martín
Affiliation:
Alzheimer's Disease Research Unit, Queen Sofia Foundation, Carlos III Institute of Health, Madrid, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims

To describe validation process of the new apathy scale for institutionalized dementia patients (APADEM-NH).

Methods

100 elderly, institutionalized patients with diagnosis of probable Alzheimer Disease (AD) (57%), possible AD (13%), AD with cerebral vascular disease (CVD) (17%), Lewy Bodies Dementia (11%) and Parkinson associated to dementia (PDD) (2%). All stages of the disease severity according to the Global Deterioration Scale (GDS) and Clinical Dementia Rating (CDR) were assessed. The Apathy Inventory (AI), Neuropsychiatric Inventory (NPI), Cornell scale for depression, and the tested scale were applied. Re-test and inter-rater reliability was carried out in 50 patients. The feasibility and acceptability, reliability, validity, and measurement precision were analyzed.

Results

APADEM-NH final version consists of 26 items and 3 dimensions: Deficit of Thinking and Self-Generated behaviors (DT): 13 items, Emotional Blunting (EB): 7 items, and Cognitive Inertia (CI): 6 items. Mean application time was 9.56 minutes and 74% of applications were fully computable. All subscales showed floor and ceiling effect lower than 15%. Internal consistency was excellent for each dimension (Cronbach’s α DT = 0.88, α EB = 0.83, α CI= 0.88);Test-retest reliability for the items was kW=0,48-0,92; Inter-rater reliability reached kW values 0.84-1.00; The APADEM-NH total score showed a low/moderate correlation with apathy scales (Spearman ρ, AI =0.33; NPI-Apathy= 0,31), no correlation with depression scales (NPI-Dementia = -0.003; Cornell= 0,10), and high internal validity (ρ =0.69 0.80).

Conclusions

APADEM-NH is a brief, psychometrically acceptable, and valid scale to assess apathy in patients from mild to severe dementia and discerning between apathy and depression.

Type
P01-493
Copyright
Copyright © European Psychiatric Association2011
Submit a response

Comments

No Comments have been published for this article.